AstraZeneca - Company Information
AstraZeneca Plc is a global biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines, inc...Read more
Headquarters
Contact
Linkedin
Company Size10,000+
Stock SymbolAZN
Websiteastrazeneca.com
TypePublic
AstraZeneca Technology Stack
Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by 6sense, used by AstraZeneca
AstraZeneca Employee Profiles
Are you looking for the decision-makers at AstraZeneca? Get their email address, phone numbers, and other details from Linkedin or any website. Install and uncover AstraZeneca’s employee details in less than 30 secs.
Sign-up for 6sense Revenue AI™ for Sales
To find emails, direct dials, and more for prospects across the web.
Sign Up TodayDownload the 6sense Chrome Extension to get verified contact data of AstraZeneca employees
Install Now
AstraZeneca News & Press Releases
Sales prospecting needs to be timely and appropriate for the person and organization you are contacting. Following the most recent company news, alerts, and updates about the leads you are currently working on is the simplest and most convenient way to stay on top of them. Here are AstraZeneca latest news, alerts and updates.
AstraZeneca to acquire cell therapy specialist Gracell in deal worth up to $1.2bn
AstraZeneca (AZ) has announced that it will be acquiring Gracell Biotechnologies in a deal worth up to $1.2bn, marking a significant boost to the Anglo-Swedish drugmaker's pipeline of cell therapies across oncology and autoimmune diseases.
2 Jan 2024
AstraZeneca to Acquire Icosavax in Deal Valued at Approximately $1.1 Billion
AstraZeneca announced a definitive agreement to acquire Icosavax, a US-based clinical stage biopharmaceutical company focused on developing vaccines using a protein virus-like particle (VLP) platform.
2 Jan 2024
Astra to Acquire Chinese Biotech to Boost Cancer Pipeline
AstraZeneca Plc agreed to acquire Chinese cell therapy developer Gracell Biotechnologies Inc. for as much as $1.2 billion as the British drug giant bolsters its bets on medical innovation in the world's second-biggest economy.
27 Dec 2023
AstraZeneca to Acquire Gracell in $1.2 Billion Deal to Further Cell Therapy Goals
AstraZeneca announced Tuesday it would acquire Gracell Biotechnologies in a deal valued at up to $1.2 billion. Gracell is a Chinese biopharmaceutical company that focuses on cancer drug development. AstraZeneca said in a press release that it plans on buying the company to further its cell therapy ambitions.
26 Dec 2023
AstraZeneca: A $1.1B Shot In The Arm From Icosavax Acquisition
AstraZeneca acquires Icosavax, expanding its respiratory vaccine portfolio and offering potential benefits for both companies. Read here why AZN is a Buy.
13 Dec 2023
AstraZeneca to acquire Icosavax in $1.1b deal
AstraZeneca stated on Tuesday that it will acquire U.S. based biopharmaceutical firm Icosavaz in a deal valued at approximately $1.1 billion. Under the terms of the deal, the tender offer will initiate at $15.
13 Dec 2023
FAQs for AstraZeneca
Explore frequently asked questions about AstraZeneca’s business, including founding details, header quarters, information on technology stack, industry listing, and other details.
What is AstraZeneca's official website?
The official website of AstraZeneca is astrazeneca.com You can find their contact number, email address, and headquarters by clicking here.
How many employees are working at AstraZeneca?
What industry is AstraZeneca in?
What is AstraZeneca's tech stack?
Where are AstraZeneca's headquarters?
Get instant access to B2B contact data across the web
Sign Up Today
